Nowadays we are able to mimic natural structures from micro to nano scale by different biofabrication methods. As an example: electro spinning is able to build-up a nanofiber network which looks nearly similar to fibrin, but is completely different in biological response. The structure is just one factor, which influence the fate of implants with regard to their remodelling and integration in the body. Therefore, the further (bio)functionalization of materials to influence the long-term function of implants is an important keyfactor in implantology.
The current issue of BioNanoMaterials is focusing on different aspects of biofunctionalization to improve the functionality or to avoid negative side effects of the biomaterials after implantation. Fehér et al. [1] describe such a new method of microgel-functionalisation of biodegradable fibre materials to avoid negative biological side-effects by the pH drop induced during the bulk degradation process.
Drug delivery systems as a controllable functionalization system are of high clinical relevance. Wulf et al. [2] have developed a tunable drug delivery system based on chitosan/polyacrylic acid polyelectrolyte multilayers, which offers an interesting toolbox for different applications. The specific implication of site-selective antibodies for drug-eluting stents is given by Petersen et al. [3] .
Biofunctionalisation by cells is promising a biological active behaviour of the implant. One of the highest hurdles in implantology is the hemocompatibility of technical/artificial devices. Therefore, the endothelial cell is in the focus of research as natural barrier between the blood phase and the implant. Klopsch et al. [4] therefore have investigated the spray technology as possible method of endothelialisation. This technology finally could be of interest with regard to high surface cell lining. One example of large surface endothelialisation is given by Neusser et al. [5] , who have developed a specific textilebased gas membrane for biohybrid lung devices.
Cellular functionalisation is just as good as the basic "cell" component. The optimal cell source is therefore essential. Böer et al. [6] have investigated the use of adipose tissue-derived mesenchymal stem cells with regard to (pre-) vascularized vascular grafts. This could be also interesting for other approaches of complex organ reconstruction, which requires a prevascularization for adequate nutrition supply.
The editors are aware that this issue can just highlight some of the multiple aspects in (bio)functionalisation. We hope that our selection of the manuscripts will stimulate your work towards innovative applications and you will enjoy this issue!
